The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022. Pfizer Inc on Tuesday said the final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its …
Read More »